Belladona and Arnica

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Belladona and Arnica
Generic name: MENTHOL
Manufacturer: Dannso Corp./d.b.a. Essential Products
Product type: HUMAN OTC DRUG
SPL set ID: fc4e63e4-cebc-49ff-8900-7238261d0fe0
SPL ID: 24945e94-4a9e-4b95-8dc6-ae70e050d7fa
Version: 1
Effective date: 2026-05-28
Source export date: 2026-09-28
Source partition: 6
Source file: https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/e0861bcde1444ef952820955caafc6f3fd29783e5ade07a13d933aa3336b399f/drug-label-0006-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:36:34

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Belladona and Arnica	openfda.brand_name
generic name		MENTHOL	openfda.generic_name
manufacturer name		Dannso Corp./d.b.a. Essential Products	openfda.manufacturer_name
ndc	package	70242-133-05	openfda.package_ndc
ndc	product	70242-133	openfda.product_ndc
ndc11	package	70242013305	derived:openfda.package_ndc
rxcui		2744725	openfda.rxcui
spl id		24945e94-4a9e-4b95-8dc6-ae70e050d7fa	id
spl set id		fc4e63e4-cebc-49ff-8900-7238261d0fe0	set_id
unii		L7T10EIP3A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Use only as directed. Do not use : on wounds or damaged skin with a heating pad on children under 12 years of age on irritated skin with a bandage on eyes or mucous membranes Ask a doctor before use if redness is present on the affected area. Stop use and ask a doctor if : excessive irritation develops condition worsens symptoms persist for more than 7 days symptoms clear up and occur again within a few days If pregnant or breast-feeding, ask a health professional before use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.